Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Drugs

News Release: Abortion Activist Sues FDA over Regulation of Dangerous Drugs 

Reckless Push to Expand Mail-order Abortion Pills from Overseas Jeopardizes Women’s Health and Safety

 

Washington, D.C.  – Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List, released the following response to a lawsuit seeking to stop U.S. Food and Drug Administration (FDA) enforcement of the regulation of dangerous abortion drugs shipped into the United States from overseas:

 

“It’s ludicrous that Rebecca Gomperts from Aid Access is suing the FDA, a government agency charged with protecting the public health of women by assuring the safety and efficacy of any drug. Far from being safe and effective, abortion pills from Aid Access have been shown to be damaged and contaminated, and these tainted drugs have caused serious—and sometimes even fatal—bacterial infections and excessive bleeding in women, said Dr. Tara Sander Lee, CLI’s Senior Fellow and Director of Life Sciences. “It is fully within the FDA’s jurisdiction to protect women from harm and prevent these dangerous abortion pills from getting into the hands of any more women. That Aid Access is attempting to stop the FDA from doing their job proves they have no intention of ensuring the health and safety of women in the U.S.”

 

Aid Access is also linked to Women on Web, a pro-abortion activist group that illegally sends abortion drugs by mail to women in countries where abortion is prohibited or limited, without any in-person evaluation by a doctor, and Women on Waves, an abortion boat that sails around performing abortion on international waters.

 

CLI experts have previously criticized flawed research purporting to show that self-administered, self-reported chemical abortions are not dangerous to women. AbortionDrugFacts.com, a new website developed with input from CLI’s team of experts and pro-life partners, aims to give women the information they need to protect their health and safety before they go through a chemical abortion, to have a second chance to change their mind after initiating one or to recover from the trauma they may already have experienced as a result of taking abortion drugs. In addition, the site provides women who have been hurt by the abortion pill an opportunity to share their story and/or make a confidential report to the FDA.

 

Charlotte Lozier Institute was launched in 2011 as the education and research arm of Susan B. Anthony List. CLI is a hub for research and public policy analysis on some of the most pressing issues facing the United States and nations around the world. The Institute is named for a feminist physician known for her commitment to the sanctity of human life and equal career and educational opportunities for women.  The 175th anniversary of Dr. Charlotte Denman Lozier’s birth occurred on March 16, 2019.

###

Latest Posts

November 21, 2024 Abortion Reporting: Idaho (2023) November 18, 2024 Abortion Reporting: Oregon (2023) November 13, 2024 IVF Industry Regulation in the United States: Changes Are Needed to Protect Embryonic Children and their Families

You Might Also Be Interested In

Abortion Reporting: Idaho (2023)

November 21, 2024
Please login to bookmarkClose

Abortion Reporting: Oregon (2023)

November 18, 2024
Please login to bookmarkClose

Abortion Reporting: Alabama (2023)

November 13, 2024
Please login to bookmarkClose

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image